BioVaxys Technology Corp. (CNSX:BIOV) acquired TAETSoftware Corp for CAD 1.9 million on March 16, 2023. Under the terms of the transaction, BioVaxys acquired all of the issued and outstanding shares of TAETSoftware in exchange for 24,500,000 common shares, with an additional 2,500,000 common shares payable upon the successful testing of the beta version of the application to TAETSoftware's shareholders. Post acquisition, Jay Dhaliwal, the Founder and CEO of TAETCo and developer of the TAET application will act as consultant to BioVaxys to assist with the commercial development of TAET.

BioVaxys Technology Corp. (CNSX:BIOV) completed the acquisition of TAETSoftware Corp on March 16, 2023.